HR 2244
115th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Medical research
Mental health
User charges and fees
Patient Experience in Research Act of 2017
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 5, 2017
Referred to the Subcommittee on Health.
Apr 28, 2017
Referred to the House Committee on Energy and Commerce.
Apr 28, 2017
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Patient Experience in Research Act of 2017
This bill requires the Food and Drug Administration to carry out a pilot project under which sponsors of new drugs or biological products agree to evaluate: (1) the distress experienced by patients in clinical trials for medications intended to treat a serious condition, and (2) the effects of providing support to distressed patients on the outcome of a clinical trial. The user fee is waived for new drug applications that include data from such an evaluation.
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
2
Cite this page
U.S. Congress. (2026). H.R. 2244: Patient Experience in Research Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2244/
"H.R. 2244: Patient Experience in Research Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2244/.
H.R. 2244, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2244/.
[H.R. 2244: Patient Experience in Research Act of 2017](https://openamerica.io/bill/115-HR-2244/)